DCF — BRONXCARE HEALTH SYSTEM
Enterprise Value: $102.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$102.7M
Enterprise Value
$7.7M
PV of Cash Flows
$95.0M
PV of Terminal Value
$152.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $896.5M | $31.7M | 4.0% | $-8.5M | $-7.8M |
| Year 2 | $923.4M | $41.9M | 5.0% | $-1.9M | $-1.6M |
| Year 3 | $951.1M | $52.7M | 6.0% | $5.2M | $3.9M |
| Year 4 | $979.6M | $59.2M | 6.0% | $9.0M | $6.2M |
| Year 5 | $1.0B | $63.5M | 6.0% | $11.2M | $6.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $102.7M. Terminal value accounts for 93% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$870.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.030394502051255917
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5